Nephrectomy for metastatic renal cell carcinoma: Indiana University experience

Urology

Volumn 62, Issue 4, 2003, Pages 636-640

  Mosharafa, Ashraf ^a   Koch, Michael ^a   Shalhav, Arieh ^a   Gardner, Thomas ^a   Logan, Theodore ^a   Bihrle, Richard ^a   Foster, Richard ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; INFERIOR CAVA VEIN; INTRAOPERATIVE PERIOD; KIDNEY CARCINOMA; KIDNEY METASTASIS; LAPAROSCOPIC SURGERY; LENGTH OF STAY; MALE; MEDICAL ASSESSMENT; NEPHRECTOMY; PATIENT SELECTION; PERIOPERATIVE PERIOD; POOR GENERAL CONDITION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL MORTALITY; UNIVERSITY HOSPITAL;

EID: 0141784099     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00682-4     Document Type: Article

References (8)

1. Flanigan R.C., Salmon S.E., Blunenstein B.A., et al. Nephrectomy followed by interferon alpha-2b compared with interferon alpha-2b alone for metastatic renal-cell cancer. N Engl J Med. 345:2001;1655-1659.
2. Mickish G.H.J., Garin A., Van Poppel H., et al. Radical nephrectomy plus interferon-alpha-based immunotherapy compared with interferon alpha alone in metastatic renal-cell carcinoma a randomized trial . Lancet. 358:2001;966-970.
3. Roberston C.N., Linehan W.M., Pass H.I., et al. Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells. J Urol. 144:1990;614-617.
4. Tannock I.F. Editorial removing the primary tumor after cancer has spread . N Engl J Med. 345:2001;1699-1700.
5. Walther M.M., Yang J.C., Pass H.I., et al. Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma. J Urol. 158:1997;1675-1678.
6. Naithon J., Kaplan A., Dorey F., et al. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion long term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy . J Urol. 162:1999;46-50.
7. Tigrani V.S., Reese D.M., Small E.J., et al. Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma a retrospective analysis . Urology. 55:2000;36-40.
8. Walther M.M., Lyne J.C., Libutti S.K., et al. Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma a pilot study . Urology. 53:1999;496-501.